Discover

IRMD
IRADIMED CORPORATION
98.04
2 x 70.16
2 x 122.18
bid
ask
+
2.48
2.60%
2 @ 04:00 PM
98.04 +0.00 (0.00%)
Ytd0.78%
1y62.02%
94.95
day range
99.10
55.11
52 week range
107.90
Open96.38Prev Close95.56Low94.95High99.10Mkt Cap1.25B
Vol154.32KAvg Vol132.05KEPS1.83P/E53.57Forward P/E41.63
Beta0.92Short Ratio4.32Inst. Own60.98%Dividend0.80Div Yield0.84
Ex Div Date05-15Earning07-3050-d Avg90.36200-d Avg90.921yr Est118.00
Earning
DateForEstimateReportedSurprisesurprise %
2026-05-012026-030.450.490.048.89%
2026-02-102025-120.490.540.0510.20%
2025-11-032025-0900.47N/AN/A
2025-08-012025-060.450.490.048.89%
2025-05-052025-030.430.42-0.01-2.33%
2025-02-132024-120.450.44-0.01-2.22%
Upgrade / Downgrade
DateFirmActionFromTo
2026-04-02Freedom BrokerUpgradeBuy
2025-02-14Roth MKMUpgradeBuyBuy
2024-08-02Roth MKMUpgradeBuyBuy
2021-08-02Roth CapitalUpgradeBuy
2017-07-31Roth CapitalUpgradeNeutralBuy
2016-10-05Roth CapitalDowngradeBuyNeutral
Profile
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
Insider Holder
DateNameRelationQuantityDescription
2026-02-12ALLEN MONTY KDirector21.00KSale
2025-12-10CHIPRIN JEFFOfficer687.00Conversion of Exercise of derivative security
2026-06-17GLENN JOHN FChief Financial Officer11.94KConversion of Exercise of derivative security
2025-12-10HAWKINS JAMES BDirector29.65KConversion of Exercise of derivative security
2026-06-03SCHAREN-GUIVEL HILDA FREDERIQUEDirector5.60KSale
2026-05-31SUSI ROGER EChief Executive Officer0.00Sale
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30Blackrock Inc.967.79K94.88M7.57%
2026-03-30Renaissance Technologies, LLC440.71K43.21M3.45%
2026-03-30Copeland Capital Management, LLC359.33K35.23M2.81%
2026-03-30Vanguard Capital Management LLC358.62K35.16M2.81%
2026-03-30Kayne Anderson Rudnick Investment Management LLC349.32K34.25M2.73%
2026-03-30Nine Ten Capital Management LLC334.49K32.79M2.62%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund259.57K25.45M2.03%
2026-04-29iShares Trust-iShares Russell 2000 ETF190.71K18.70M1.49%
2026-03-30Virtus Equity Trust-Virtus KAR Small-Cap Growth Fund139.50K13.68M1.09%
2026-03-30JNL Series Trust-JNL Multi-Manager Small Cap Growth Fund95.68K9.38M0.75%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund90.49K8.87M0.71%
2026-03-30T. Rowe Price Small-Cap Value Fund, Inc.82.35K8.07M0.64%
Dividend
DividendDate
0.22026-05-15
0.22026-02-23
0.52025-12-17
0.172025-11-14
0.172025-08-18
0.172025-05-20